Related Experiment Video
Updated: May 21, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study
Sigrun Alba Johannesdottir1, Ellen T Chang, Frank Mehnert
1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. saj@dce.au.dk
Background:
Nonsteroidal anti-inflammatory drugs (NSAIDs) may prevent the development of cancer by inhibiting cyclooxygenase (COX) enzymes, which are involved in carcinogenesis. Therefore, the authors of this report examined the association between NSAID use and the risk of squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and malignant melanoma (MM).
Methods:
From 1991 through 2009, all incident cases of SCC (n = 1974), BCC (n = 13,316), and MM (n = 3242) in northern Denmark were identified. Approximately 10 population controls (n = 178,655) were matched to each case by age, gender, and county of residence. The use of aspirin, other nonselective NSAIDs, or selective COX-2 inhibitors was ascertained through a prescription database. Conditional logistic regression analyses adjusted for potential confounders were used to compute odds ratios as estimates of incidence rate ratios (IRRs).
Results:
For NSAIDs overall, ever use (>2 prescriptions) compared with nonuse (≤2 prescriptions) was associated with a decreased risk of SCC (IRR, 0.85; 95% confidence interval [CI], 0.76-0.94) and MM (IRR, 0.87; 95% CI, 0.80-0.95), especially for long-term use (≥7 years) and high-intensity use (>25% prescription coverage during the total duration of use). NSAID use was not associated with a reduced risk of BCC overall (IRR, 0.97; 95% CI, 0.93-1.01), but the risk of BCC at sites other than the head and neck was reduced in association with long-term use (IRR, 0.85; 95% CI, 0.76-0.95) and high-intensity use (IRR, 0.79; 95% CI, 0.69-0.91). All estimates of reduced risk were driven primarily by the use of nonselective NSAIDs and older COX-2 inhibitors (diclofenac, etodolac, and meloxicam).
Conclusions:
The current results indicated that NSAID use may decrease the risk of SCC and MM.
Insights
Nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of squamous cell carcinoma (SCC) and malignant melanoma (MM). This association was particularly strong with long-term and high-intensity NSAID use.
Area of Science:
- Oncology
- Pharmacology
- Epidemiology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes, potentially preventing cancer development.
- The study investigated the link between NSAID consumption and the incidence of skin cancers.
Purpose of the Study:
- To examine the association between NSAID use and the risk of squamous cell carcinoma (SCC), basal cell carcinoma (BCC), and malignant melanoma (MM).
Main Methods:
- A population-based case-control study in northern Denmark (1991-2009) identified 1974 SCC, 13,316 BCC, and 3242 MM cases.
- Approximately 178,655 population controls were matched to cases.
- NSAID use (aspirin, nonselective NSAIDs, COX-2 inhibitors) was assessed via prescription records, with analyses using conditional logistic regression.
Main Results:
- Overall NSAID use was linked to a reduced risk of SCC (IRR, 0.85) and MM (IRR, 0.87), especially with long-term or high-intensity use.
- NSAID use did not significantly reduce overall BCC risk (IRR, 0.97), but long-term/high-intensity use lowered BCC risk at non-head/neck sites.
- Reduced risk estimates were primarily driven by nonselective NSAIDs and older COX-2 inhibitors.
Conclusions:
- NSAID consumption may be associated with a decreased risk of developing SCC and MM.
- The findings suggest a potential chemopreventive role for NSAIDs against certain skin cancers.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
12:37Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer Prevention
Some...
Cancer Prevention
Some...
Acne Infection
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Mutagenicity and Carcinogenicity